Hepatocellular carcinoma (HCC) is the most common primary liver cancer, representing the
sixth leading cause of cancer and the third leading cause of cancer-related mortality. Patient …

Abstract Changes in body composition are associated with poor outcomes in cancer patients
including hepatocellular carcinoma (HCC). Sarcopenia, defined as the loss of skeletal …

This is the first American Association for the Study of Liver Diseases (AASLD) practice
guidance on the management of malnutrition, frailty, and sarcopenia in patients with …

Sarcopenia is defined by muscle loss and muscle dysfunction. Sarcopenia is classified into
primary and secondary types, based on the cause. Primary sarcopenia is mainly aging …

Background & Aims Previous prognostic scores for transarterial chemoembolization (TACE)
were mainly derived from real-world settings, which are beyond guideline …

Several staging systems for hepatocellular carcinoma (HCC) have been developed. The
Barcelona Clinic Liver Cancer staging system is considered the best in predicting survival …

Objective: To evaluate the prevalence of sarcopenia among European patients with
resectable hepatocellular carcinoma (HCC) and to assess its prognostic impact on overall …

Background & Aims Multiple staging systems have been proposed for hepatocellular
carcinoma (HCC). However there is no consensus regarding which system provides the best …

Background and Aims Itaconate, a metabolite of the tricarboxylic acid cycle, plays anti‐
inflammatory roles in macrophages during endotoxemia. The mechanisms underlying its …

Background & Aims The role of hepatic resection for hepatocellular carcinoma (HCC) in
different Barcelona Clinic Liver Cancer (BCLC) stages is controversial. We aimed at …